Commercial Executive in Biopharmaceuticals with a long and consistent track record of driving performance on global, regional, and country level (Global, EMEA and Russia, Europe, Mid Europe & Nordics, Switzerland, and Denmark) in large pharma, large biotech and start-up companies• Leading organisations up to 200 employees to success through consistent high engagement levels and by building high performing leadership and brand teams who work seamlessly together• VP & General Manager Mid Europe and Nordics in Amarin building Mid Europe country organisations, optimizing Mid Europe and Nordics structure, negotiating access and launching Vazkepa (cardiovascular disease) across the region• General Manager Switzerland in Amgen leading the second largest affiliate among Mid-SizedMarkets in Europe, delivering significant value and volume growth and key contributor to shaping the healthcare agenda in Switzerland as board member of Interpharma• European cross-functional Launch Lead for Amgen’s key priority brand and blockbuster(Repatha, cardiovascular disease) driving countries to clear market leadership andpreparing Europe for outcomes data launch• Brand leadership delivering above expectations of the largest brand in AstraZeneca (Crestor,cardiovascular disease, >$5B revenue)• Launch excellence of several major brands in cardiovascular, metabolic disease,neuroscience, oncology and respiratory leading to world class results• Consistent strong collaborations with key stakeholders to improve company results andpatient outcomes (scientific societies, KOL´s, specialists, GP´s, payers, patient advocacygroups, politicians, authorities, and media)• Fluent in English, German, Scandinavian languages and Danish